BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9156247)

  • 1. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
    Bader P; Hölle W; Klingebiel T; Handgretinger R; Benda N; Schlegel PG; Niethammer D; Beck J
    Bone Marrow Transplant; 1997 Apr; 19(7):697-702. PubMed ID: 9156247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
    Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
    Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study.
    Choi SJ; Lee KH; Lee JH; Kim S; Chung HJ; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
    Bone Marrow Transplant; 2000 Aug; 26(3):327-32. PubMed ID: 10967574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of chimerism in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation].
    Furukawa T; Hashimoto S; Inano K; Yamazaki F; Takeda H; Kakihara T; Yano T; Abe T; Higuchi W; Toba K; Takahashi M; Koike T; Aizawa Y
    Rinsho Ketsueki; 2001 Jun; 42(6):488-95. PubMed ID: 11505528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia.
    Huisman C; de Weger RA; de Vries L; Tilanus MG; Verdonck LF
    Bone Marrow Transplant; 2007 Mar; 39(5):285-91. PubMed ID: 17262061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
    Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
    Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.
    Barrios M; Jiménez-Velasco A; Román-Gómez J; Madrigal ME; Castillejo JA; Torres A; Heiniger A
    Haematologica; 2003 Jul; 88(7):801-10. PubMed ID: 12857560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse.
    Serrano J; Román J; Herrera C; Castillejo JA; Navarro JA; Reina ML; González MG; Rodriguez MC; Pascual A; Sánchez J; Torres A
    Bone Marrow Transplant; 1999 Mar; 23(5):475-82. PubMed ID: 10100562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic approach to molecular quantitative determination of mixed chimaerism following allogeneic bone marrow transplantation: an analysis of its applicability in a group of patients with severe aplastic anaemia.
    Hassan R; Bonamino MH; Braggio E; Lobo AM; Seuánez HN; Tabak DG; Zalcberg IR
    Eur J Haematol; 2004 Sep; 73(3):156-61. PubMed ID: 15287911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
    Bader P; Kreyenberg H; Hoelle W; Dueckers G; Handgretinger R; Lang P; Kremens B; Dilloo D; Sykora KW; Schrappe M; Niemeyer C; Von Stackelberg A; Gruhn B; Henze G; Greil J; Niethammer D; Dietz K; Beck JF; Klingebiel T
    J Clin Oncol; 2004 May; 22(9):1696-705. PubMed ID: 15117992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia.
    Hoelle W; Beck JF; Dueckers G; Kreyenberg H; Lang P; Gruhn B; Führer M; Niethammer D; Klingebiel T; Bader P
    Bone Marrow Transplant; 2004 Jan; 33(2):219-23. PubMed ID: 14647253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection.
    Dubovsky J; Daxberger H; Fritsch G; Printz D; Peters C; Matthes S; Gadner H; Lion T; Muller-Bérat N
    Leukemia; 1999 Dec; 13(12):2059, 2060-9. PubMed ID: 10602430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
    Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
    Pediatr Transplant; 1998 May; 2(2):150-6. PubMed ID: 10082448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
    Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
    Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive DNA polymorphisms in following chimerism after allogeneic bone marrow transplantation.
    Grubic Z; Stingl K; Cecuk Jelicic E; Zunec R; Kastelan A; Serventi Seiwerth R; Bogdanic V; Labar B; Kerhin Brkljacic V
    Clin Transplant; 2005 Oct; 19(5):586-90. PubMed ID: 16146548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT.
    Bader P; Hölle W; Klingebiel T; Handgretinger R; Niethammer D; Beck J
    Anticancer Res; 1996; 16(4A):1759-63. PubMed ID: 8712697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.